Arcutis Biotherapeutics, Inc. ARQT Accrued sales deductions
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept arqt:AccruedSalesDiscounts.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s accrued sales deductions?
- Arcutis Biotherapeutics, Inc. (ARQT) reported accrued sales deductions of $99.53M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s accrued sales deductions changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s accrued sales deductions increased by 111.7% year-over-year, from $47.01M to $99.53M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s accrued sales deductions?
- Over 2 years (2023 to 2025), Arcutis Biotherapeutics, Inc.'s accrued sales deductions has grown at a 160.1% compound annual growth rate (CAGR), from $11.58M to $78.31M.